Driving Change: What the PCC Working Group Has Learned and What’s Next
The Predictable Cost of Care Working Group (the PCC) is a multi-organizational effort comprised of pharmaceutical and biotech manufacturers, pathway vendor organizations, community practices, IDNs, and payers. The purpose of the PCC is to inform pathway developers and practices about a greater span of costs than simply drug costs; provide relevant context in competitive situations; and identify areas for quality improvement, efficiency. In this discussion, Dr Lalan Wilfong, SVP of value-based care at Thyme Care, explores how granular analysis of total cost of care enables more accurate risk prediction and actionable care strategies, highlighting the complexity and opportunity in creating predictive, patient-centered frameworks to improve outcomes and reduce costs in oncology.
